Qiagen Non-GAAP EPS of $0.62 in-line, revenue of $540M beats by $11.51M
Source: SeekingAlpha
2026-02-04 16:48:24 ET
- Qiagen press release ( QGEN ): Q4 Non-GAAP EPS of $0.62 in-line.
- Revenue of $540M (+3.6% Y/Y) beats by $11.51M .
- 2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CER) vs $2.21B consensus and adj. diluted EPS of at least $2.50 CER vs $2.65 consensus
- Shares -3.7% .
Read the full article on Seeking Alpha
For further details see:
Qiagen Non-GAAP EPS of $0.62 in-line, revenue of $540M beats by $11.51M
Qiagen N.V.
NASDAQ: QGEN
QGEN Trading
1.58% G/L:
$41.16 Last:
892,000 Volume:
$41.83 Open:
QGEN Latest News
March 10, 2026 05:05:00 pm
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QGEN Stock Data
$10,633,318,293
203,932,295
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
NL
Venlo
